tradingkey.logo
tradingkey.logo
Search

Protagonist Therapeutics Inc

PTGX
Add to Watchlist
145.070USD
+0.090+0.06%
Close 09-22 16:00ET
9.33BMarket Cap
LossP/E TTM

PTGX Financials

See Protagonist Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
9.33B
Dividend TTM
0.00
P/E TTM
-80.38
EPS TTM
-1.80
Revenue
46.02M
Net Profit
275.19M
ROE
-17.06%
ROA
-15.94%

Protagonist Therapeutics Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
2.47/2.08
Revenue / Forecast
213.47M/203.76M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
551.12%2.47
131.40%0.06
-132.81%-0.69
-14.73%-0.62
-9.63%-0.55
-105.43%-0.19
366.96%2.11
6.70%-0.54
26.28%-0.50
610.92%3.41
165.16%0.45
---0.58
---0.68
---0.67
---0.69
---1.90
----
----
----
----
Revenue
3749.17%213.47M
99.03%56.37M
-95.64%7.44M
0.79%4.71M
33.09%5.55M
-88.89%28.32M
184.40%170.64M
--4.67M
--4.17M
--254.95M
--60.00M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-62.08%859.00K
315.61%25.72M
52.51%8.62M
-21.56%10.29M
Net Profit
568.35%162.85M
132.46%3.78M
-133.71%-44.38M
-18.46%-39.34M
-13.57%-34.77M
-105.62%-11.65M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
179.94%27.34M
-9.20%-34.10M
6.28%-38.46M
-61.13%-33.73M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
12.78%-20.93M
-95.42%-36.91M
-335.45%-33.80M
Net Margin
112.17%76.28%
116.31%6.71%
-873.40%-596.80%
-17.53%-834.87%
14.67%-626.96%
-150.60%-41.15%
69.38%77.17%
---710.37%
---734.73%
--81.32%
--45.56%
----
----
----
----
---350.62%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
--100.00%
----
----
----
----
Debt to assets ratio
----
----
--0.00%
----
----
----
--0.00%
----
----
----
--0.00%
----
----
--0.00%
--0.00%
----
----
----
----
----
Revenue
3749.17%213.47M
99.03%56.37M
-95.64%7.44M
0.79%4.71M
33.09%5.55M
-88.89%28.32M
184.40%170.64M
--4.67M
--4.17M
--254.95M
--60.00M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-62.08%859.00K
315.61%25.72M
52.51%8.62M
-21.56%10.29M
Operating profit
477.65%158.77M
81.11%-3.65M
-139.72%-50.35M
-11.98%-46.42M
-8.37%-42.04M
-109.36%-19.31M
450.05%126.78M
-8.16%-41.45M
8.41%-38.79M
672.75%206.31M
163.12%23.05M
-18.65%-38.33M
-2.20%-42.35M
-70.63%-36.02M
1.35%-36.52M
4.78%-32.30M
-34.20%-41.44M
12.11%-21.11M
-96.58%-37.02M
-336.52%-33.93M
Net Profit
568.35%162.85M
132.46%3.78M
-133.71%-44.38M
-18.46%-39.34M
-13.57%-34.77M
-105.62%-11.65M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
179.94%27.34M
-9.20%-34.10M
6.28%-38.46M
-61.13%-33.73M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
12.78%-20.93M
-95.42%-36.91M
-335.45%-33.80M
Current assets
33.96%807.15M
1.25%613.46M
-2.38%577.57M
23.00%586.42M
5.54%602.53M
-3.46%605.86M
66.39%591.64M
46.75%476.77M
80.14%570.92M
166.21%627.55M
46.28%355.58M
17.45%324.88M
4.15%316.94M
-30.97%235.74M
-28.66%243.08M
-15.58%276.62M
-18.16%304.30M
19.62%341.52M
7.96%340.74M
60.51%327.69M
Total current liabilities
4.71%37.18M
-1.60%34.55M
-4.13%45.44M
0.82%44.94M
-14.60%35.51M
-12.02%35.11M
122.80%47.40M
59.97%44.58M
57.50%41.58M
71.81%39.91M
-31.77%21.27M
-24.18%27.87M
-34.15%26.40M
-46.55%23.23M
-29.16%31.18M
-6.13%36.75M
-6.71%40.09M
25.90%43.46M
9.38%44.02M
1.54%39.16M
Total assets
23.33%885.54M
-6.02%697.46M
-10.28%668.19M
16.20%701.69M
16.82%718.01M
17.93%742.13M
108.05%744.73M
82.98%603.86M
91.79%614.63M
162.35%629.28M
44.38%357.95M
16.95%330.02M
3.21%320.47M
-31.13%239.86M
-28.69%247.93M
-24.39%282.17M
-23.18%310.51M
16.85%348.30M
7.16%347.69M
71.72%373.18M
Total liabilities
-11.98%44.00M
-20.90%41.99M
-22.97%53.48M
-21.81%56.25M
-31.81%49.99M
-22.88%53.08M
226.36%69.43M
158.16%71.94M
177.69%73.31M
190.54%68.83M
-34.18%21.27M
-27.73%27.87M
-37.94%26.40M
-49.07%23.69M
-32.21%32.32M
-11.39%38.56M
-9.09%42.53M
20.08%46.52M
6.27%47.67M
-8.83%43.52M
Total equity
25.98%841.54M
-4.87%655.47M
-8.97%614.71M
21.34%645.44M
23.40%668.02M
22.95%689.05M
100.58%675.29M
76.04%531.91M
84.08%541.32M
159.26%560.44M
56.15%336.68M
24.03%302.15M
9.74%294.07M
-28.37%216.17M
-28.14%215.61M
-26.10%243.62M
-25.03%267.98M
16.37%301.78M
7.30%300.02M
94.39%329.66M
Net operating income
861.13%219.05M
-139.04%-48.94M
-26.72%-36.98M
93.05%-1.94M
-110.71%-28.78M
557.05%125.36M
-272.04%-29.18M
-4.70%-27.86M
1123.79%268.62M
20.14%-27.43M
153.61%16.96M
-5.60%-26.61M
-92.43%-26.24M
8.81%-34.35M
-17.43%-31.64M
11.48%-25.20M
42.47%-13.63M
-30.98%-37.67M
-42.78%-26.94M
-74.80%-28.47M
Net investment
-104.43%-2.43M
196.28%90.89M
659.48%48.81M
71.94%-58.55M
162.20%54.81M
-1654.97%-94.40M
85.76%-8.72M
-1439.27%-208.71M
-442.05%-88.12M
-38.21%6.07M
-1657.48%-61.29M
-123.67%-13.56M
-25.83%25.76M
319.53%9.83M
-85.88%3.94M
228.11%57.27M
346.85%34.73M
34.11%-4.48M
137.45%27.87M
17.40%-44.71M
Net financing
233.09%9.74M
104.26%23.37M
-29.62%2.84M
-53.04%5.66M
13.72%2.92M
58.95%11.44M
664.90%4.03M
-65.88%12.05M
-97.62%2.57M
-72.80%7.20M
-4.70%527.00K
5093.38%35.31M
15807.65%108.17M
56.35%26.46M
-74.55%553.00K
-50.76%680.00K
-99.46%680.00K
1628.80%16.93M
-98.29%2.17M
-81.99%1.38M

FAQs

What is the total revenue of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total revenue reached 46.02M, with a year-on-year change of 434.43M.

What are the current assets of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its current assets were 577.57M, with a year-on-year change of -2.38.

What are the total assets of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total assets of Protagonist Therapeutics Inc were 668.19M, with a year-on-year change of -10.28.

What are the total liabilities of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total liabilities of Protagonist Therapeutics Inc were 53.48M, with a year-on-year change of -22.97.

What is the total equity of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total equity of Protagonist Therapeutics Inc was 614.71M, with a year-on-year change of -8.97.

What is the net operating income of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net operating income of Protagonist Therapeutics Inc was -158.13M, with a year-on-year change of -162.54.

What is the net investment of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net investment of Protagonist Therapeutics Inc was -49.33M, with a year-on-year change of 83.53.

What is the net financing of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net financing of Protagonist Therapeutics Inc was 22.86M, with a year-on-year change of -11.56.

What is the Earnings Per Share (EPS) of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.05, with a year-on-year change of -145.80.

What is the net income of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net income was -130.15M, with a year-on-year change of -147.29.

What is the net margin of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net profit margin was -282.83, with a year-on-year change of -546.50.

What is the Return on Equity (ROE) of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -20.18, with a year-on-year change of -137.10.

What is the Return on Assets (ROA) of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -18.42, with a year-on-year change of -136.91.

What is the operating profit of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its operating profit was -158.13M, with a year-on-year change of -162.54.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.